Active ingredients: paclitaxel
What it is used for
Primary treatment of ovarian cancer in combination with a platinum agent. Treatment of metastatic carcinoma of the ovary and of the breast after failure of standard therapy. Adjuvant treatment of node positive breast cancer administered sequentially to doxorubicin and cyclophosphamide. Treatment of metastatic cancer of the breast, in combination with trastuzumab (Herceptin), in patients who have tumours that overexpress HER-2 and who have not received previous chemotherapy for their metastatic disease. Paclitaxel, in combination with gemcitabine (Gemzar), is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/ neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Treatment of non-small cell lung cancer (NSCLC).
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Intravenous
- Store below 25 degrees Celsius
- Protect from Light
- Lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
clear, slightly viscous solution, colourless to pale yellow solution, free of visible particles
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient paclitaxel
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)